$JSEBLU
BLU will report later in the month( Interims) - 20th Feb. It’s important to understand that this is the proverbial “ Kitchen Sink” numbers. As such we should see a T/S with a < 20% decrease due to the IPO.
Simply put BLU converted old loans and data worth R13bn and sold
It in the IPO for R9bn ( lower than what th street expected). Thus, leaving an Impairment of R4bn . This is at least in the current price as the IPO happened in Nov ‘25 and should not come as any surprise on reporting!!
For some context , you should know that of the R7,5 bn in data they sold for CellC Equity , BLU only paid R4,4bn ( as CellC gave a Discounts). In addition the R3,75bn Debt to Equity conversion - the real number BLU placed was R1,9bn ( originally) before the rollup over the years!
BLU also sold CEC back to CellC so BLUs EBITDA will be as a consequence lower ( what they get back is 50% earnings in CC) . But the offsets here would be the interest cost they no longer have to pay on CEC loan -R230m a year. The new EBItDA I’m suggesting could be around R800-1bn ( from 1,4bn ) pa. If we look at the post IPO in CellC - BLUs “Investment in Assoc” will be weighted at 49,8% of CellC profits / dividends.
The bigger picture here is - BLU is likely on a GROUP level to report earnings ( combined with CC) of 120-150c for the year. This will be high FCF returns ( esp in 2027/8). It’s likely to expect there will be pro forma numbers due to consolidation , to de consolidation.A NB reminder here is that the impairment is on the CellC Asset sale , it’s NOT an earnings related impairment!! If anything we expect CellC to come in and beat guidance from the PLS!
Now for the good news , this is the extent of it all. We now have two very low cost , low debt operators with Fintech platforms and hence forth crispy clean ( Aug 26) AFS. For BLU it’s now about adding the “ Treasury functionality into the next 6 months an update on their Energy strategy ( where they have just started working with 2-3 Municipalities in SA - High margin biz).
Additional kickers come in the form of SPECIAL DIVIDEND ( 80% probability ) mentioned in Oct last year, my best guess is this is 20-30c range ( outside chance 50c). BLU is also owed R1,4bn on the BEE Sale which moves to R1,65bn by year end. This is 18% of their market cap. This gives them HUGE ammo for capital allocation - Buyback and further special dividends ( if BEE holders get bank funding or sell to new BEE investor at year end)We are also very confident they will initiate an interim dividend in Aug with a focus yield over 5% (IMO)!
Now, CellC aren’t expected to pay a dividend this year but it’s suggested there’s a chance shareholders can vote to elect one still. The market has them paying 7% in 27 and 9,6% in ‘28.
This will be a big contributor to BLU and should see CellC rerate from 6 PE to at least 10 vs peers at 12-15 PE presently. Finally, don’t rule out any corporate action - CellC unbundle could happen in some form ( can’t rule out) or new strategic BEE investors ( I would assume once price moves 20-30% from IPO level).
The price has come back to a great accumulate zone - -950c a good risk reward for a high FCF ( Yes - there will be some Operating CF movements for CellC data purchased that we need to strip out) company looking to reward shareholders after years on the back foot. They have it all to prove.
To recap BLU s EBITDA is likely 1bn 50% CellC R1,5bn = 2,5bn ( rough numbers ). BLUs mkt cap is R8,5bn 1bn debt -cash this stock is trading on a EV / EBITDA < 4 !! FCF is likely to be 10-15% on a “forward basis”. This is what Gold miners are basically pushing through now after the commodity rallies. You can own a high FCF biz like BLU without the cyclical nature of mining companies!
The brothers bought 20m shares in November ( representing 2,4% of co) at roughly 960c \- in Nov 25 , before the closed period!
This is Anchors Top pick I’m told!!
DYOR!!